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A nutritious diet low in calories improves the health
and extends the life span of rodents. Recent studies
identified a gene, SIR2, which encodes an NAD-
dependent deacetylase and may mediate the effects
of calorie restriction. In this review, we discuss SIR2
genes and calorie restriction in the lower organisms
yeast and Drosophila. We then describe the physio-
logical changes in mammals during calorie restriction
and how they may lead to the observed health bene-
fits. We summarize the roles of mammalian Sirt1 in
mediating these changes in tissues and endocrine
systems and propose that Sirt1 regulates calorie re-
striction by sensing low calories and triggering physi-
ological changes linked to health and longevity.
We have known since the 1930s that limiting the food
consumed by laboratory rodents increases their life
span (McCay et al., 1935). Since then, food restriction
has been shown to achieve this result in a broad
spectrum of life forms from yeast (Lin et al., 2000) to
likely include primates (Ingram et al., 2004). Nutritional
studies in rodents indicated that it was the number of
calories in the diet that was the key parameter (Masaro,
1984; Richardson, 1985; Weindruch and Walford, 1988),
giving rise to the term calorie restriction (CR) which we
will use in this review. Typically, CR diets feature a level
of food that is 60%–70% of what animals would eat ad
libitum. At the physiological level, the effects of CR are
very well characterized (Weindruch and Walford, 1988),
beginning with an acute phase upon imposition of the
diet followed by an adaptive period of several weeks to
reach a stable, altered physiological state. A lower
body temperature, lower blood glucose and insulin
levels, and reduced body fat and weight characterize
this altered state (Koubova and Guarente, 2003). The
CR animals also appear to be more resistant to external
stressors, including heat and oxidative stress (Sohal
and Weindruch, 1996). Organs are typically smaller in
CR animals but to varying degrees; for example, the
brain does not shrink in size at all.
Evolutionarily, CR may represent adaptation to scar-
city in a boom and bust cycle. Any organism that could
slow aging and reproduction in times of scarcity and
remain able to reproduce when food reappeared would
enjoy a competitive advantage over neighbors that
could not (Harrison, 1989; Holliday, 1989). In lower or-
ganisms, this strategy has been elaborated to include
cases where the organism actually builds specialized*Correspondence: leng@mit.edu
2 Present address: Laval Hospital Research Center, Quebec,
G1V4G5, Canada.body forms for survival, for example spores in microbes
and dauer larvae in C. elegans.
The nature of metabolic changes in CR animals has
been a subject of considerable debate. It is clear that
the animals have reduced energy stores, i.e., glycogen
and fat. However, whether there is a change in their
metabolic rate, the rate at which they consume oxygen
and produce CO2, has been in dispute. Initial studies
reported a reduction in metabolic rate in CR animals
(Weindruch and Walford, 1988), and this finding fit with
the theory that oxidative damage from reactive oxygen
species (ROS) causes aging (Harman, 1956); a reduc-
tion in metabolic rate, it was argued, would decrease
ROS production during electron transport and respira-
tion. However, other studies found that the metabolic
rate, when normalized to the lean body mass of the
animals, did not decrease during CR (Masaro et al.,
1982; McCarter et al., 1985; McCarter and Palmer,
1992). This latter finding was important because it ex-
ploded a myth in the field, that the total metabolic activ-
ity over the lifetime of the animal was fixed. Clearly,
the CR animals enjoyed more total metabolic activity
adjusted for body weight over their lifetimes than did
the ad libitum controls. To understand the relationship
between CR and metabolic rate more fully, it will be
necessary to interrogate individual tissues, such as
muscle, instead of whole-body determinations. In bud-
ding yeast, as well as the nematode C. elegans, CR has
been shown to actually result in an increase in respira-
tion (Lin et al., 2002; Houthoofd et al., 2002; Hulbert et
al., 2004).
One of the most striking features of CR is that it ap-
pears to forestall or prevent altogether many late-onset
diseases (Weindruch and Walford, 1988). For example,
CR extends life span in certain lab strains of mice
which normally die of cancer. CR will even extend the
shortened life span of p53−/− mice (Hursting et al., 2003;
Berrigan et al., 2002), which die of early cancers that
appear in the absence of the tumor suppressor. CR also
extends life span in Fischer rats, which normally die
of kidney disease. More generally, CR has been shown
efficacious in mouse models of a variety of diseases
(Lane et al., 1999; Stern et al., 2001).
A central question is whether the benefits of CR are
a passive result of lower caloric intake or the conse-
quence of an active regulatory program that recognizes
food scarcity and programs the resulting salutary ef-
fects. Recent genetic and molecular studies in model
organisms, in fact, suggest that CR may be a regulated
process, with the SIR2 gene playing an important role.
This gene, silent information regulator 2, was first iden-
tified because it mediates gene silencing in yeast (Rine
and Herskowitz, 1987). In this review, we will trace re-
cent progress in elucidating mechanisms of CR in yeast
and Drosophila. We will then review tantalizing but in-
complete new findings in mammals suggesting that the
SIR2 ortholog, Sirt1, may mediate a broad array of
physiological effects that occur in animals on a CR diet.
Understanding CR at the molecular level of detail may
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rthe health benefits of this dietary regimen.
l
aCR in Yeast
Several years ago, it was shown that diluting the energy e
source in yeast growth media, glucose, extended the
replicative life span of mother cells (Lin et al., 2000), u
wi.e., the number of times mothers divide to yield daugh-
ters. This simple model system of CR has brought a f
cconsiderable advance in our understanding of the pro-
cess and some controversy, all of which will be dis- b
tcussed below. The yeast system seemed cogent be-
cause genetic interventions thought to lower glucose s
taction also extended the life span, including mutating
genes of glucose utilization (hexokinase) or signaling g
t(components of the protein kinase A pathway).
It was of obvious importance to address whether the s
llongevity engendered by CR was a regulated process.
The major genetic determinant of replicative life span a
tin yeast to emerge from genetic studies is SIR2; loss-
of-function mutations shortened life span, and in- t
Rcreased gene dosage extended it (Kaeberlein et al.,
1999). The SIR2 ortholog in C. elegans was similarly e
fshown to be a key determinant of life span in that or-
ganism (Tissenbaum and Guarente, 2001). The fact that a
yeast and C. elegans diverged from a common ances-
tor about one billion years ago suggests that all de- z
Lscendants of that ancestor, including mammals, will
possess SIR2-related genes involved in regulating their t
plife span (Figure 1).
The enzymatic activity of the SIR2 product was found r
Tto be a highly unusual one, NAD-dependent histone de-
acetylase (Imai et al., 2000; Landry et al., 2000; Smith w
eet al., 2000). Later studies showed that the mammalian
Sirt1 enzyme deacetylates many nonhistone substrates T
t(see below). NAD is cleaved to produce nicotinamide
(NA) and acetyl-ADP-ribose each reaction cycle (Tanner d
het al., 2000; Tanny and Moazed, 2001). The unusual en-
zymatic activity of Sir2 suggested that this protein e
tsenses the metabolic state of cells and sets the life
span accordingly (Guarente, 2000). This surmise was eFigure 1. Evolutionary Tree Highlighting
Yeast and C. elegans
The role of SIR2 genes in determining life span
has been conserved in yeast and C. elegans.
This suggests that a SIR2-like gene must
have carried out this function in the ancestral
precursor organism of yeast and C. elegans
(X) about one billion years ago. Further, any
descendents of X, including mammals, are
expected to have SIR2 genes that control
their life span, unless this function has been
lost in that lineage.trengthened by the realization that SIR2-related genes
egulate formation of the specialized survival forms in
ower organisms, spores in yeast (Margolskee, 1988),
nd dauer larvae in C. elegans (Tissenbaum and Guar-
nte, 2001).
Several observations suggest that CR in yeast is reg-
lated by SIR2. First, CR did not extend the life span
hen SIR2 was deleted (Lin et al., 2000, 2002). This
inding was tempered by the fact that sir2 mutants ac-
umulate abundant quantities of extra-chromosomal ri-
osomal DNA circles, which limit the life span of wild-
ype cells (Sinclair and Guarente, 1997) and greatly
horten the life span in sir2 mutants. However, when
hese circles were mitigated by also deleting another
ene (FOB1), the life span of sir2 mutants was restored
o approximate that of the wild-type, but the strain was
till unresponsive to CR. Second, CR increased the si-
encing activity of SIR2 in vivo (Lin et al., 2002). Third,
n activator of the Sir2 enzyme, resveratrol, was iden-
ified by screening compounds and was shown to ex-
end yeast replicative life span (Howitz et al., 2003).
esveratrol required the SIR2 gene for this longevity
ffect. Notably, resveratrol and CR did not synergize to
urther extend the life span, again suggesting that SIR2
nd CR are in the same pathway.
The mechanism by which CR activates the Sir2 en-
yme has been controversial. Based on the findings of
in et al. (2002, 2004), a molecular pathway could be
raced from caloric intake to long life (Figure 2). In this
athway, CR increases oxygen consumption and respi-
ation, at the expense of fermentation (Lin et al., 2002).
his shift is logical considering that fermentation is a
ay cells can produce ATP and also store excess en-
rgy in the form of ethanol when glucose is abundant.
he shift to respiration was shown to trigger a concomi-
ant reduction in NADH (Lin et al., 2004), an electron
onor for respiration. NADH itself is a competitive in-
ibitor of SIR2, so its reduction during CR would be
xpected to upregulate the enzyme and thereby extend
he life span. Consistent with this model, knocking out
lectron transport blocked the effect of CR on life span,
Review
475Figure 2. Pathways by Which CR Extends the Life Span of Yeast
Mother Cells
The pathways are described in the text.and overexpressing NADH dehydrogenase, the enzyme
that shunts electrons from NADH to the electron trans-
port chain (ETC), increased the life span in high
glucose.
The finding that CR triggers a more efficient use of
glucose via an increase in respiration may be analo-
gous to a known metabolic shift that occurs in mam-
mals during CR. There is a transition in muscle cells
from using glucose, which is metabolized in fed animals
(in part) fermentatively (producing lactate), toward the
use of fatty acids, which are metabolized oxidatively.
This metabolic shift spares glucose for the brain and
correlates with the characteristic enhancement of insu-
lin sensitivity in muscle and liver. Whether this shift may
be due to or elicit any changes in the activity of mam-
malian Sirt1 has not yet been determined.
The above model for activation of Sir2p by CR in
yeast, however, has been challenged by the findings of
Anderson et al. (2002) that the NAD salvage pathway
plays a key role in CR (Figure 2). They showed that CR
upregulates levels of an enzyme, Pnc1p, that synthe-
sizes NAD from its cleaved products, NA and ADP-
ribose. This upregulation, however, was quantitatively
less than that induced by cell stressors, such as high
osmolarity, and was not observed in microarray analy-
sis (Lin et al., 2002). Since NA has also been shown
to inhibit the SIR2 enzyme, it was suggested that CR
extends life span by reducing NA in cells, thereby
upregulating Sir2p (Figure 2). Consistent with this
model, deleting PNC1 reduced or eliminated the ability
of CR to extend life span (Anderson et al., 2003). In-
deed, it is quite possible that the NAD salvage pathway
functions in parallel to changes in NADH to regulate
Sir2. A key experiment to further validate this model
would be a demonstration that NA levels are in fact al-
tered in CR cells. It is unlikely, however, that NA func-
tions as the only mediator of CR, since the regimen was
completely effective in cells deleted for PNC1 if the ex-
cess NA was depleted from cells (Lin et al., 2004). In
this latter case, the NAD/NADH ratio presumably medi-
ated the activation of Sir2p and its accompanying lon-
gevity.More recently, it was reported that CR is independent
of SIR2 in a different, unrelated strain of yeast (Kaeber-
lein et al., 2004; Figure 2). This finding is of potential
interest and suggests that there may be more than one
pathway that can mediate CR in yeast. Vast differences
in yeast strains have been observed in other cases. No-
tably, two pleiotropic regulatory genes, MPT5 (UTH4)
and SSD1, can exert large effects on yeast life span
and are both polymorphic among a set of different labo-
ratory strains (Kaeberlein and Guarente, 2002). It will be
important to see what genes play a role in the novel
pathway of CR identified by Kaeberlein et al. (2004) and
whether it bears mechanistic similarities to the SIR2
pathway. Moreover, a critical question is whether either
pathway has been conserved in higher organisms. In
this regard, recent findings in Drosophila and mammals
are very suggestive that at least the role of SIR2 has
been conserved.
CR in Drosophila
Life span in Drosophila can be extended by diluting the
yeast that, along with glucose, comprises the fruit fly’s
diet (Clancy et al., 2001). This regimen is properly
termed food restriction since it does not impose any
obvious energy limitation, but we will continue to use
the term CR for convenience. Several experiments sug-
gest that CR works by activating the Drosophila SIR2
ortholog, Sir2. First, CR increases the levels of Sir2
mRNA in Drosophila (Rogina et al., 2002). Second, the
SIR2 activator resveratrol also extended the life span in
Drosophila (Wood et al., 2004). As in yeast, this exten-
sion was not observed in Sir2 mutants. However,
resveratrol did not further extend the long life span of
CR flies, indicating that Sir2 works in the same pathway
as CR. Third, CR did not extend the life span of Sir2
mutant flies (Rogina and Helfand, 2004). Fourth, over-
expression of Sir2 using a UAS/Gal4 driver extended
the life span, and this longevity was not further in-
creased by CR. These findings suggest that the role of
SIR2 as mediator of CR on life span has been con-
served in metazoans.
However, caution must be applied in interpreting
many of the studies on the relationship between CR
and specific genes. For example, it is known that cer-
tain mutations in the insulin/IGF-1 signaling pathway
can extend the life span in mice, C. elegans, and flies
(this subject is reviewed by Kenyon [2005] in this issue
of Cell). The long-lived dwarf mice, which are missing
the growth hormone-IGF-1 axis and other pituitary hor-
mones due to mutation in the pit-1 gene (Brown-Borg
et al., 1996), enjoy a robust further extension in their life
span on a low-calorie diet (Bartke et al., 2001). This
finding led the authors to surmise that CR and IGF-1
extended life span by independent mechanisms.
But another study showed a complex relationship
between CR and a different mutant altered in insulin/
IGF-1 pathway signaling in Drosophila, termed chico
(Clancy et al., 2001). By looking at the life spans of flies
at many food concentrations, the authors found that
chico shifted the dose-response curve, as though the
mutants were ingesting or sensing less food. By com-
paring the wild-type and chico flies at only two food
concentrations, one could have fortuitously chosen
Cell
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acluded that CR and chico acted by totally separate
pmechanisms. As it stands, the detailed relationship be-
mtween chico and CR is not yet known, but the two may
Iwell overlap. It remains to be seen how important this
tcautionary note will be in interpreting the relationship
ebetween IGF-1 and CR in mammals and, more gen-
merally, in the many studies of CR that employ only two
tfood concentrations.
lAnother study in Drosophila harks back to the ques-
ption of whether CR is a regulated process. Upon shift-
iing flies from a normal to a CR diet, the authors noted
man instantaneous shift in mortality rates from a high
tone, typical of normal food, to a low one indistinguish-
table from that of age-matched flies raised on a CR diet
etheir whole lives (Mair et al., 2003). The opposite shift
eyielded the converse instantaneous change. This puzzling
tfinding indicates that CR affects only the short-term
urisk of death and that there is no legacy of the diet
oearlier in life. How can this be? Clearly, if diet caused a
fsteady accumulation of damage, which eventually
pkilled the fly, and CR simply reduced the rate of damage
2accumulation, there would have to be a memory of
iearlier dietary effects. Rather, the findings suggest one
of two possibilities, either of which indicates that the
teffects of CR are regulated. CR may set the threshold
hof damage that can cause death, without actually af-
gfecting the rate of damage accumulation. Alternatively,
aand more speculatively, a shift to CR may cause an ac-
itual reversal of damage to the level evident in flies on
ma CR diet their whole lives. In this case, it is even more
hbewildering how a shift out of CR could suddenly in-
cduce a level of damage to match the control flies.
p
eCR in Mice
v
Clearly, the effect of CR in mammals is complex, affect-
w
ing many organs and physiological axes. The discus-
w
sion below will focus on effects that may be integrated
p
with recent findings of the roles of Sirt1 in mammalian d
physiology. Whether Sirt1 will prove truly decisive in i
mediating the effects of CR in mammals is not yet c
known, but possible connections have been made, m
which form the core of the presentation. d
Metabolic Considerations s
As discussed above, studies of how CR affects metab- u
olism have traced a long and tortuous path. But recent l
studies suggest a novel possibility; it may be advanta- i
geous to increase metabolism during CR, at least in t
some tissues. As mentioned above, respiration is in- i
creased by CR in yeast (Lin et al., 2002) and C. elegans (
(Houthoofd et al., 2002; Hulbert et al., 2004). Three S
studies suggest that increased metabolism may pro- C
mote long life in mammals. First, the fat insulin receptor h
KO mice (FIRKO) had low fat deposits because of the i
absence of insulin signaling in white adipose tissue g
(WAT) (Blüher et al., 2003). Moreover, these mice ate a
more than weight-matched wild-type mice yet they had d
a lower body weight, indicating that they have a higher i
than normal metabolic rate. Strikingly, these mice lived v
longer than controls. Second, mice genetically engi- i
neered to have their C/EBPα gene replaced with a se- f
cond copy of C/EBPβ were also hypermetabolic, in this i
scase due to increased metabolism in WAT. These micelso lived longer than controls (Chiu et al., 2004). Third,
cross-sectional study of individual mice showed a
ositive correlation between oxygen consumption, i.e.,
etabolic rate, and life span (Speakman et al., 2004).
n this last study, the mouse-to-mouse variation in me-
abolism was due to differences in the degree to which
lectron transport was coupled to ATP synthesis in
itochondria. The longer-lived mice had mitochondria
hat were more uncoupled. This could signify higher
evels in the mitochondrial membrane of uncoupling
roteins, which discharge the proton gradient by allow-
ng proton leakage from the cytoplasm back to the
itochondrial matrix (Merry, 2002). The respiration in
his case would be dissipated to generate heat, rather
han used for ATP synthesis. Previously, one might have
xpected CR mice to be less uncoupled to allow more
fficient utilization of energy to make ATP. Now it is
empting to speculate that CR mice are actually more
ncoupled than controls, perhaps due to upregulation
f mitochondrial uncoupling proteins by CR. Recent
indings, in fact, suggest that the levels of uncoupling
roteins 2 (Xiao et al., 2004) and 3 (Sreekumar et al.,
002) may well increase during CR, although these find-
ngs need to be further substantiated.
Why would a higher degree of uncoupling be a good
hing? CR reduces the size of animals, likely creating a
igher surface area to volume ratio and potentially
reater heat loss. The lower body temperature of CR
nimals is consistent with this idea. The CR mice may
ncrease uncoupling proteins in metabolic tissues,
uscle, liver, and brown adipose tissue (specialized in
eat production) in an attempt to bridge this heat defi-
it. There are several possible ways that greater uncou-
ling may then lead to longer life span. The extra
lectron transport dissipated by uncoupling may acti-
ate a regulatory pathway to extend life span, much like
hat happens in yeast during CR. Whether this would
ork by an altered NAD/NADH ratio and involve Sir2
roteins remains speculative. Another possible benefit
erives from the argument that the production of ROS
s greatest when electrons are stalled in the ETC. Be-
ause of proton leakage down the gradient, uncoupled
ice would avoid hyperpolarization of the mitochon-
rial membrane, which could otherwise lead to the
talling of electrons in the ETC. In this way, partially
ncoupled electron transport may actually generate a
ower level of ROS. This idea is supported by the find-
ng that macrophages isolated from mice deficient in
he uncoupling protein 2 (UCP2−/−) produce more ROS
n response to infection than wild-type macrophages
Arsenijevic et al., 2000).
tress Resistance
R is known to increase the resistance to oxidative and
eat stress (Sohal and Weindruch, 1996). It is easy to
magine how heightened stress resistance would trig-
er longer life span. One possibility, for example, is that
greater ability to detoxify ROS or repair oxidative
amage would slow cellular decay. Consistent with this
dea, microarray analysis showed that many genes in-
olved in managing oxidative stress were upregulated
n the aging brain of mice, changes that were less mani-
est in CR controls (Lee et al., 2000). In this regard, it is
ntriguing that genetic regulators of mammalian life
pan can also increase resistance to stress. Absence
Review
477Figure 3. Model for How SIRT1 Mediates
Some of the Effects of CR in Mammals
The right shows repression of three proapo-
ptotic factors by SIRT1, as discussed in the
text. The left shows hypothetical regulation
of endocrine responses by SIRT1. The sug-
gestion is that the endocrine changes and
the higher threshold for apoptosis in hor-
mone-responsive cells are integrated re-
sponses; together they do not increase the
incidence of cancer but rather help potenti-
ate stress resistance and longevity.of the protein p66 shc caused an increase in stress re-
sistance; KO mice and cells from KO mice were more
resistant to oxidative or UV-induced stress (Migliaccio
et al., 1999). p66 KO mice were shown to live longer
than wild-type, an indication that resistance to stress-
induced apoptosis at the cellular level may correlate
with life span in mammals. Stress resistance may also
occur in a cell nonautonomous way. Serum from CR
mice was shown to endow cultured fibroblasts with en-
hanced stress resistance compared to serum from ad
libitum controls (Cohen et al., 2004). Interestingly, the
CR serum triggered a higher level of the mammalian
SIR2 ortholog, Sirt1, in the fibroblasts, which was par-
tially reversed by adding IGF-1 and insulin to the serum
(Cohen et al., 2004). Thus, endocrine changes are also
likely to play an important role in stress regulation.
The connection between Sirt1 and stress resistance
appears to be quite extensive. Like the yeast Sir2, Sirt1
is an NAD-dependent deacetylase (Imai et al., 2000).
Unlike the yeast enzyme, Sirt1 appears to target many
proteins that are not histones. The first example of this
was p53, which was shown to be deacetylated and
downregulated by Sirt1 (Luo et al., 2001; Vaziri et al.,
2001; Langley et al., 2002). Thus, Sirt1 negatively regu-
lates p53-dependent apoptosis in response to cellular
damage. A second family of regulators targeted by
Sirt1 are Foxo or forkhead proteins. Like p53, Foxo pro-
teins can respond to stress and trigger apoptosis.
Again, Sirt1 was shown to deacetylate and downregu-
late Foxo1, 3, and 4 and thus repress Foxo-mediated
apoptosis (Brunet et al., 2004; Motta et al., 2004). Sirt1
also deacetylated and downregulated the Foxo coacti-
vator p300. However, there may be a wrinkle in the case
of Foxo regulation; certain Foxo targets, such as the
DNA repair gene GADD45, appeared to be upregulated
by Sirt1 (Brunet et al., 2004; Daitoku et al., 2004; van
der Horst et al., 2004), although the mechanism for this
is not yet understood. Similarly, the C. elegans sir-2.1
requires the daf-16 forkhead protein to increase the life
span (Tissenbaum and Guarente, 2001).
In addition, Sirt1 was found to deacetylate the DNA
repair protein Ku70, allowing it to bind to and inactivatethe proapoptotic factor Bax (Cohen et al., 2004). In
summary, Sirt1 appears to target numerous cellular
factors, thereby resulting in a higher threshold for apo-
ptosis. This constitutes a two-edged sword in which
cell and organ survival may be balanced against tumor
surveillance, a topic that will be considered below. An
exception to this rule may occur in the case of NF-kB,
which Sirt1 also deacetylated and downregulated
(Yeung et al., 2004). This regulation by Sirt1 sensitized
NF-kB-containing cells to apoptotic killing by the cy-
tokine TNFα. Why Sirt1 would work oppositely on this
p53-independent apoptotic pathway is not clear but
may relate to exigencies of cells where NF-kB is partic-
ularly important, such as cells of the immune system. In
this case, it may be of paramount importance to control
inflammation, a process shown by microarray data to
be enhanced in aging mice (Lee et al., 2000), by down-
regulating the transcriptional activator of cytokine
genes, NF-kB.
Fat Regulation
There is increasing evidence that mammalian aging is
regulated in part by fat storage. This stems from theo-
retical considerations, as well as experimental data in
mice. WAT affords mammals an opportunity to sense
diet and send appropriate signals to coordinate aging
in all organs. WAT stores fat as triglycerides when food
is abundant. When food is scarce, as in CR animals,
cells shed their fat and animals are very lean. WAT is
also an endocrine tissue and secretes hormones such
as leptin and adiponectin (Kershaw and Flier, 2004). The
full range of hormones made by WAT has not yet been
elucidated. WAT can thus sense whether food is abun-
dant or scarce and exert organismal effects by the
levels of hormones it secretes. Questions currently on
the table in this emerging area include (1) How does the
amount of fat stored in WAT regulate hormone synthe-
sis? (2) Are different hormones regulated differentially
by fat storage? (3) Which hormones (if any) play deci-
sive roles in regulating aging?
Yet the notion that WAT may regulate aging remains
controversial. On the one hand, CR animals are lean
and live longer than controls. On the other, when ani-
Cell
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The figure shows three tissues, white adipose tissue (WAT), metabolic tissues (muscle and liver), and pancreatic β cells as they are integrated
in a regulatory circuit. Chronic high food intake triggers an increase in blood glucose, which activates β cells to produce insulin. Over the
longer term, this diet will induce β cell proliferation and ultimately failure. The elevated blood insulin levels signal WAT to store energy as fat
(triglycerides). The increase in stored fat, in turn, alters levels of circulating hormones coming from the WAT. This endocrine change, perhaps
coupled with higher levels of circulating fat, creates insulin resistance in the metabolic tissues. Finally, the insulin resistance further elevates
blood glucose. This metabolic cycle can trigger type 2 diabetes and is mitigated by CR, possibly by the action of SIRT1.mals within a CR or ad libitum group were analyzed, the q
tcorrelation between body fat and life span was inverted
(Bertrand et al., 1980). These latter data were less ro-
cbust than the comparison between groups because the
differences in fat content (and life span) is much less a
nwithin a group than between groups. The idea that WAT
may regulate aging is greatly strengthened by the find- F
aings that the FIRKO mice and C/EBP knockin mice de-
scribed above are very lean and live long. A recent p
tstudy in Drosophila showed that flies with a reduced
fat body (which is an analog of mammalian WAT and n
ealso liver) live longer than controls (Giannakou et al.,
2004). Even if WAT mass does not directly control life s
mspan per se, it likely mediates many age-associated
metabolic disorders such as type 2 diabetes or dyslipi- a
idemia (Barzilai and Gabriely, 2001), which can in turn
decrease the period of life. c
oWhy would we expect Sirt1 to regulate WAT?
Changes in this and perhaps other endocrine tissues N
tmight help solve a dilemma, namely, if Sirt1 represses
p53, why wouldn’t it cause cancer (certainly an undesir- S
table property for a survival factor)? One answer is to
suppose that Sirt1 exerts effects on hormones, includ- g
cing growth factors, which override cell-autonomous ef-
fects on apoptosis (Figure 3). Indeed, global changes in b
shormones do occur in CR animals, as discussed above.
Such changes may permit or even mandate raising the t
threshold for apoptosis in hormone-responsive cells.
The combined effect of changes in hormones and a s
thigher threshold for apoptosis in responsive cells may
not favor cancer in dividing cells at all. In postmitotic W
Tcells, in which growth factor signaling is not conse-uential, it may be a clear advantage to the survival of
he organism to raise the bar for apoptosis.
An especially important hormonal axis during CR
omprises WAT, metabolic tissue (muscle and liver),
nd pancreatic β cells, which produce insulin. There is
o doubt that crosstalk exists between these tissues.
igure 4 depicts the effects of calorie excess on this
xis. Surges in blood glucose will activate β cells to
roduce insulin acutely and over the long term can lead
o β cell proliferation and ultimately failure. Insulin sig-
als WAT to store fat as triglycerides, an efficient en-
rgy reservoir because of its highly reduced state. The
tore of triglycerides then influences the levels of hor-
ones that are produced by the white fat cells, for ex-
mple triggering an increase in leptin and a decrease
n adiponectin (Combs et al., 2003). These hormonal
hanges, in turn, can influence the insulin sensitivity
f metabolic tissues, which respond to the hormones.
otably, since adiponectin is known to increase sensi-
ivity to insulin in metabolic tissues (Pajvani and
cherer, 2003), its decrease can lead to insulin resis-
ance, which would further exacerbate the rise in blood
lucose. This vicious cycle may be central in many
ases of type 2 diabetes. CR will antagonize this cycle
y lowering blood glucose and insulin, reducing fat
tores, and increasing adiponectin and insulin sensi-
ivity.
Does Sirt1 play a role in regulating the adaptive re-
ponse to CR in these tissues? In WAT, Sirt1 was found
o be expressed and to repress the key regulator of
AT, the nuclear receptor PPARγ (Picard et al., 2004).
he repression of PPARγ is expected to slow the differ-
Review
479Figure 5. Model for a Pathway of CR in Mammals
Food deprivation upregulates SIRT1 in WAT, as measured by asso-
ciation with transcription factor PPARγ via its negative cofactor
NCoR at promoter sites in target genes such as aP2, other fat stor-
age genes, and hormones. SIRT1 thus modulates these genes and
changes the output of circulating hormones and fat. This signals a
coordinated response to food scarcity in the various tissues of the
animal and elicits a slowing of organismal aging. It is likely that
processes affecting fertilization and perhaps gestation are also im-
pacted to slow reproduction.entiation of precursor cells into white adipocytes and
to downregulate fat storage in existing WAT. In fact,
Sirt1 levels did regulate the degree of differentiation in
the cell culture model, 3T3-L1 cells; inhibition of endog-
enous Sirt1 favored differentiation, and overexpression
blocked it (Picard et al., 2004). Moreover, Sirt1 bound
directly to the PPARγ-negative cofactors, NCoR and
SMRT, and associated with PPARγ DNA binding sites in
promoters of fat-specific genes. These and other find-
ings show that Sirt1 can function as a negative regula-
tor of PPARγ.
In addition, Sirt1 is important for changes in the me-
tabolism of fat in WAT in mice. Food deprivation causes
the lipolysis of triglycerides in WAT and the release of
free fatty acids to the blood, from which they are taken
up and oxidized by metabolic tissues. Sirt+/− mice did
not mobilize as much fat to the blood as wild-type after
overnight fasting showing a role of this sirtuin in fat
mobilization. Interestingly, fasting induced the binding
of Sirt1 to the PPARγ DNA binding region of the promot-
ers of fat-specific genes, where it could exert its repres-
sive effects (Picard et al., 2004; Figure 5). It is not yet
known how food deprivation induces this Sirt1 activity,
but it does not appear to greatly affect the protein
levels of Sirt1 in WAT of mice. This may contrast to rats,
where CR was found to increase levels of Sirt1 (Cohen
et al., 2004). These findings make Sirt1 a good candi-
date as a regulator of the critical axis depicted in Figure
4, at least during acute food limitation.
However, a puzzle still remains in relating these ef-fects of Sirt1 in WAT to the effects of a new class of
drugs, the thiazolidinediones (TZDs), which are activa-
tors of PPARγ in WAT. These drugs favor insulin sensi-
tivity and are therefore therapeutics for type 2 diabetes.
How can Sirt1 mediate the observed insulin sensitivity
in long-term CR if it functions as a repressor of PPARγ?
One possibility is that the activation of Sirt1 in WAT dur-
ing acute starvation is transient, and long term CR will
actually downregulate Sirt1 in WAT, thereby upregulat-
ing PPARγ. This scenario, however, seems unlikely,
given the absense of fat storage in CR animals. Another
possibility is that insulin sensitivity induced during CR
is triggered by tissues other than WAT, most likely met-
abolic tissues like muscle. For example, changes in
Sirt1 during long-term CR could increase β oxidation of
fatty acids, thereby lowering free fatty acids in the
blood and favoring insulin sensitivity. The TZGs might
also work by lowering fatty acids in the blood, but by a
different mechanism; more avid fat retention in WAT
due to the activation of PPARγ. The TZDs may also lead
to more differentiation of WAT, leading to a greater
number of smaller adipocytes that now secrete salutary
levels of important hormones. Obviously, it will be im-
portant to broaden studies beyond acute food depriva-
tion in WAT to examine the effects of Sirt1 during long-
term CR on a variety of tissues.
The Sirt1-PPARγ connection might be important in
other tissues during aging. For example, PPARγ is
known to control many biological processes in the ves-
sel wall, such as smooth muscle cell proliferation or
differentiation and lipid accumulation in macrophages
(Lee and Evans, 2002), which could well play an active
role in age-related atherosclerosis. In addition, aging is
associated with cancer progression and PPARγ ex-
pressed in several tissues where cancer typically de-
velops: colon, bladder, breast, and prostate. It is there-
fore possible that modulation of PPARγ activity by Sirt1
is another mechanism that impinges on cancer in CR
animals under conditions where apoptosis may be re-
duced.
Postmitotic Cells—CR and Neurodegeneration
In certain mouse models of neurodegenerative dis-
eases, such as Parkinson’s or Alzheimer’s, CR has been
reported to reduce age-associated neuronal loss (Matt-
son, 2003). CR has also been reported to slow declines
in psychomotor and special memory tasks, preserve
dendritic spines involved in learning, and improve the
plasticity and ability of self-repair of the brain (Mattson
et al., 2001; Weindruch and Walford, 1988). Is there any
way in which known functions of Sirt1 might preserve
neuronal integrity with age? As mentioned above, re-
pression of p53- and FOXO-mediated apoptosis by
Sirt1 may be of special importance for the long-term
maintenance of postmitotic cells such as neurons. Fur-
ther, a recent report suggests an unexpected connec-
tion between Sirt and the preservation of neuronal in-
tegrity (Araki et al., 2004). A strain of mice has been
described with a mutation, wld-s, which displays much
slower degeneration of axons in response to injury to
peripheral neurons. The mutation was found to be a
chromosomal translocation which upregulated a bio-
synthetic enzyme for NAD. In fact, NAD itself could pro-
tect neurons of wild-type mice against injury in an
in vitro assay. Amazingly, the extra NAD appeared to
Cell
480Nprotect axons from degeneration by upregulating the
tactivity of Sirt1; RNA inhibition of Sirt1 prevented the
Aprotective effect of the wld-s gene or NAD (Araki et al.,
B2004). This could mean that Sirt1 in the neuronal cell
S
body regulates genes whose products travel down the i
axon and mediate axonal survival in the face of injury. d
It will be important to test whether Sirt1 activity is al- B
tered in neurons of CR animals and to identify target a
Ngenes that may be responsible for protecting axonal
integrity after injury. B
bIn Conclusion
BCR has long been recognized for its ability to extend
Amammalian life span and to mitigate disease processes
tin many tissues. Humans have not fully harvested the
Bbenefits from the regimen, in part because of the ex-
i
treme difficulty in complying with the regimen. This may a
change as we uncover the mechanisms by which CR 8
delivers its benefits. Recent findings pinpoint Sirt1 as B
one good candidate to regulate this process in mam- i
5mals. As a foundation, Sirt1 appears to play an impor-
tant role in mediating the impact of CR in yeast and B
DDrosophila. Further, Sirt1 may regulate physiological
Bprocesses that are impacted by CR, such as fat stor-
Yage. On this basis, one would predict that mice de-
Sfective in Sirt1 would show a blunted response to CR.
S
Unfortunately, knocking out Sirt1 in the 129 strain of
Cmice causes embryonic or postnatal death due to de-
P
velopmental problems (McBurney et al., 2003; Cheng o
et al., 2003). This deleterious effect on development is d
not observed in yeast, C. elegans, or Drosophila, and C
the reasons for the lethality observed in 129 mice are o
cstill not clear. However, in outcrossed strain back-
Cgrounds, the Sirt1 knockout mice can survive and fare
Hsurprisingly well. It should be possible to test the re-
ssponse to CR in these mice as a first approximation of
t
the importance of this regulator in mediating the pro-
Ccess. Also, mice with tissue-specific Sirt1 defects or
s
which overexpress the protein should provide impor- (
tant information. Understanding how CR works may aid d
the development of drugs to deliver some of the health C
benefits of the regimen. In this respect, the path of CR m
Sresearch, which began 70 years ago, may not have too
smuch longer to go before it tangibly improves our lives.
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